Levosert (Levonorgestrel)

Levonorgestrel is a synthetic progestin that suppresses ovulation, thickens cervical mucus to block sperm, and alters the endometrium to make implantation unlikely. Delivered via an intrauterine system, it releases a low, steady hormone dose directly to the uterus, maintaining contraceptive efficacy while limiting systemic exposure.

Each Levosert device contains a fixed 52 mg of levonorgestrel, releasing about 20 µg of hormone per day for up to five years. The prescribing clinician determines the insertion timing, follow‑up schedule, and any additional care required.

Levosert is contraindicated in pregnancy (Category X) and must not be inserted in a pregnant woman. If pregnancy occurs while the device is in place, it should be removed promptly. Limited data suggest low systemic hormone levels are generally compatible with breastfeeding, but removal is advised if concerns arise.

To place an order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity of Levosert. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any temperature control) and the necessary import documentation.

Compared with copper IUDs, Levosert releases levonorgestrel, often resulting in reduced menstrual bleeding and relief of dysmenorrhea while offering similar pregnancy‑prevention efficacy. Compared with other hormonal IUS such as Mirena, Levosert contains a comparable amount of levonorgestrel and provides up to five years of use with a similar safety profile.

Levosert should be stored at room temperature, below 25 °C, in its original sealed packaging. It must be protected from moisture, direct sunlight, and extreme temperature fluctuations. The device should remain in a controlled environment until insertion to preserve the hormone reservoir’s integrity.

Levosert is inserted into the uterine cavity by a trained healthcare professional using a specialized inserter. The procedure is performed in a clinical setting after confirming the patient is not pregnant and after appropriate cervical preparation. Once placed, the device remains in situ for up to five years without further user action.

Serious but rare complications include uterine perforation during insertion, device expulsion, pelvic infection, and ectopic pregnancy if contraception fails. Users should seek immediate medical attention for severe abdominal pain, abnormal bleeding, fever, or signs of infection, as early detection can prevent further complications.

Levosert is contraindicated in women who are currently pregnant, have known or suspected uterine anomalies, active pelvic infection, unexplained vaginal bleeding, or a history of breast cancer. It should also be avoided in individuals with hypersensitivity to levonorgestrel or any component of the device. Consultation with a healthcare provider is essential before use.